EcoDrugPlus

N-Acetylated Alpha-Linked Acidic Dipeptidase 2

Ensembl ID : ENSATEG00000006835
Gene Symbol: NAALAD2
3 Cross references
340 Possible Orthologues:

P2y Purinoceptor 12-Like

Ensembl ID : ENSATEG00000015229
Gene Symbol: LOC113165670
3 Cross references
182 Possible Orthologues:

Ph_bcr_vertebrate And Rhogap_bcr Domain-Containing Protein

Ensembl ID : ENSATEG00000013988
Gene Symbol: SI:DKEY-91M11.5
3 Cross references
203 Possible Orthologues:

Pla2c Domain-Containing Protein

Ensembl ID : ENSATEG00000003977
Gene Symbol: ZGC:92162
3 Cross references
233 Possible Orthologues:

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSATEG00000024791
Gene Symbol: PTK6B
3 Cross references
160 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSATEG00000001736
Gene Symbol: PIM1
2 Cross references
250 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSATEG00000007142
Gene Symbol: PIM3
2 Cross references
196 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase-Like

Ensembl ID : ENSATEG00000015555
Gene Symbol: LOC113169980
3 Cross references
185 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase A

Ensembl ID : ENSATEG00000015487
Gene Symbol: RAF1A
3 Cross references
207 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 2

Ensembl ID : ENSATEG00000010506
Gene Symbol: ROCK2
1 Cross references
216 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSATEG00000023209
Gene Symbol: UGCG
3 Cross references
212 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSATEG00000000973
Gene Symbol: WEE1
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).